carbapenems has been researched along with Neonatal Sepsis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 5 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| Amatya, P; Baker, S; Basnyat, B; Dixit, SM; Dongol, S; Karkey, A; Manandhar, S; Nguyen, Q; Pham, DT; Rabaa, M | 1 |
| Barchia, I; Karmila, A; Ramandati, A; Zhang, L | 1 |
| Acman, M; Chiu, CH; Hamawandi, A; Lindsay, JA; Readman, JB; Sharland, M; Standing, JF | 1 |
| Adhisivam, B; Agarwal, R; Ahmed, NU; Balasegaram, M; Ballot, D; Bekker, A; Berezin, EN; Berkley, JA; Bielicki, JA; Bilardi, D; Boonkasidecha, S; Carvalheiro, CG; Chami, N; Chaurasia, S; Chiurchiu, S; Colas, VRF; Cook, A; Cousens, S; Cressey, TR; de Assis, ACD; Dien, TM; Ding, Y; Dong, H; Dramowski, A; Ds, M; Dudeja, A; Dung, NT; Ellis, S; Feng, J; Glupczynski, Y; Goel, S; Goossens, H; Hao, DTH; Heath, PT; Huertas, TM; Islam, MS; Jarovsky, D; Khan, MI; Khavessian, N; Khorana, M; Kontou, A; Kostyanev, T; Laoyookhon, P; Larsson, M; Lochindarat, S; Luca, M; Malhotra-Kumar, S; Mondal, N; Mundhra, N; Musoke, P; Mussi-Pinhata, MM; Nakwa, F; Nanavati, R; Nangia, S; Nankunda, J; Nardone, A; Nyaoke, B; Obiero, CW; Owor, M; Ping, W; Plakkal, N; Preedisripipat, K; Qazi, S; Qi, L; Ramdin, T; Riddell, A; Roilides, E; Romani, L; Roysuwan, P; Russell, NJ; Saggers, R; Saha, SK; Sarafidis, K; Sharland, M; Stöhr, W; Thomas, R; Tusubira, V; Velaphi, S; Vilken, T; Walker, AS; Wang, X; Wang, Y; Yang, Y; Zunjie, L | 1 |
| Ding, Y; Heath, PT; Hsia, Y; Sharland, M; Wang, Y | 1 |
| Dudeja, S | 1 |
2 review(s) available for carbapenems and Neonatal Sepsis
| Article | Year |
|---|---|
Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Genes, Bacterial; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Neonatal Sepsis | 2019 |
Neonatal Sepsis: Treatment of Neonatal Sepsis in Multidrug-Resistant (MDR) Infections: Part 2.
Topics: Anti-Bacterial Agents; beta-Lactamases; Blood Culture; Carbapenems; Colistin; Drug Resistance, Multiple; Enterobacteriaceae; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Klebsiella; Neonatal Sepsis | 2020 |
4 other study(ies) available for carbapenems and Neonatal Sepsis
| Article | Year |
|---|---|
A fatal outbreak of neonatal sepsis caused by mcr-10-carrying Enterobacter kobei in a tertiary care hospital in Nepal.
Topics: Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Enterobacter; Enterobacteriaceae Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Neonatal Sepsis; Nepal; Tertiary Care Centers | 2022 |
Clinical and bacteriological profile of culture-negative and culture-proven neonatal sepsis in Palembang, Indonesia.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Humans; Indonesia; Infant, Newborn; Neonatal Sepsis; Sepsis | 2022 |
Cefotaxime/sulbactam plus gentamicin as a potential carbapenem- and amikacin-sparing first-line combination for neonatal sepsis in high ESBL prevalence settings.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefotaxime; Escherichia coli; Gentamicins; Humans; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Sepsis; Prevalence; Sulbactam | 2023 |
Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS).
Topics: Anti-Bacterial Agents; Carbapenems; Cohort Studies; Humans; Infant; Infant, Newborn; Neonatal Sepsis; Prospective Studies; Sepsis | 2023 |